By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sirion Therapeutics 

3110 Cherry Palm Drive
Suite 340
Tampa  Florida  33619  U.S.A.
Phone: 813-496-7325 Fax: 813-496-7328


SEARCH JOBS


Industry
Diagnostics

Segment
Start Up





Company News
Sirion Therapeutics U.S. Rights for Eye Treatment to Bausch & Lomb (BOL) 6/3/2010 8:15:01 AM
Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes 4/26/2010 8:47:09 AM
Alcon, Inc. (ACL) Completes Acquisition of DUREZOL(TM) and ZYCLORIN(TM) from Sirion Therapeutics 3/30/2010 8:50:16 AM
Alcon, Inc. (ACL) to Purchase Ophthalmic Pharmaceutical Assets from Sirion Therapeutics 1/19/2010 10:36:37 AM
Sirion Therapeutics Announces FDA Approval of Zirgan(TM) 0.15% for Herpetic Keratitis Zirgan 9/16/2009 8:46:48 AM
Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology Annual Meeting 4/30/2009 12:15:20 PM
Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide 4/15/2009 8:23:29 AM
Sirion Therapeutics Supplemental New Drug Application for Durezol(TM) to Treat Uveitis is Accepted for Review by the FDA 3/16/2009 9:59:58 AM
Sirion Therapeutics Partners With Advanced Vision Research to Promote Products for Retinal and Meibomian Gland Health 2/17/2009 8:54:44 AM
Sirion Therapeutics New Drug Application for Ganciclovir is Accepted for Review by the FDA for the Treatment of Ocular Herpes 1/26/2009 9:57:07 AM
123
//-->